KNOTT DAVID M - Global Blood Therapeutics, Inc. ownership

Back to all holdings Add to watchlist

Global Blood Therapeutics, Inc.'s ticker is and the CUSIP is 378904108. A total of 1 filers reported holding Global Blood Therapeutics, Inc. in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.4%.

Links
Filings
Quarter-by-quarter ownership
KNOTT DAVID M ownership history of Global Blood Therapeutics, Inc.
ValueSharesWeighting
Q2 2018$936,000
+0.9%
20,710
+7.8%
0.35%
-8.4%
Q1 2018$928,000
-8.3%
19,210
-25.3%
0.38%
-5.0%
Q4 2017$1,012,000–25,724–0.40%–
 Download
Other shareholders
Global Blood Therapeutics, Inc. shareholders Q1 2018
NameSharesValueWeighting ↓
KNOTT DAVID M 19,210$928,0000.38%
View complete list of Global Blood Therapeutics, Inc. shareholders